Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 360 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pharmacist intervention Clear all

Conditions: Lupus Nephritis (LN)
Interventions: Lupus Nephritis (LN) Care Pathway; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiovascular Disease, Hypertension, Diabetes, Hyperlipidemia
Interventions: Pharmacist CVD; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Atrial Fibrillation, Stroke
Interventions: Oral anticoagulant; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Malignant Solid Neoplasm
Interventions: Medical Chart Review, Educational Intervention, Survey Administration; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Dementia, Potentially Inappropriate Medication Use, Mild Cognitive Impairment (MCI)
Interventions: e-ALIGN Patient-Portal Deprescribing; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: COVID-19
Interventions: COVID Booster text messages; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 2,600,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Telemedicine, Veterans Health, Physical Activity, Mobility
Interventions: Link Team; Behavioral
Lead sponsor: VA Ann Arbor Healthcare System; Federal
Eligibility: 50 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hypertension
Interventions: CROWN Intervention, Enhanced Usual Care; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolus
Interventions: Enoxaparin; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Herpes Zoster, Pneumococcal Infections
Interventions: Enhanced immunization delivery model, Immunization update; Behavioral · Other
Lead sponsor: Auburn University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Auburn, Alabama • Claremont, California

Conditions: Overweight and Obesity, Health Behavior
Interventions: mobile Health and Wellness Coaching, Usual Care; Behavioral
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 19 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Blood Pressure
Interventions: Community Health Worker (CHW), Remote Blood Pressure (BP) Management Program (RBPM); Behavioral · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: New Haven, Connecticut • Boston, Massachusetts • Houston, Texas + 1 more

Conditions: Male Osteoporosis
Interventions: Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, placebo tablet, Calcium citrate tablet, Vitamin D3; Drug · Dietary Supplement
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years to 85 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alzheimer Disease
Interventions: Arm 1 Education Session; Other
Lead sponsor: Daniela Moga; Other
Eligibility: 65 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolus, Reconstructive Surgery
Interventions: Enoxaparin; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Interventions: Remote monitoring; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 5
States / cities: Baltimore, Maryland • New York, New York • Chapel Hill, North Carolina + 2 more

Conditions: Hypertension
Interventions: High Intensity Intervention, Low Intensity Intervention, All- 6 month pharmacist intervention; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Acute Kidney Injury
Interventions: Study Physician/Advance Practice Provider, Nurse Navigator, Pharmacist, Patient Education; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 2,145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 9
States / cities: Birmingham, Alabama • New Haven, Connecticut • Weston, Florida + 3 more

Conditions: Opioid Abuse, Prescription Opioid Abuse
Interventions: Clinical Decision Support Tool (Moderate Risk), Clinical Decision Support Tool (High Risk), Standard of Care; Behavioral · Other
Lead sponsor: University of Utah; Other
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Cincinnati, Ohio • Salt Lake City, Utah

Conditions: Epilepsy
Interventions: Oxcarbazepine (brand name vs generic drugs), Divalproex Sodium (brand name vs generic drugs), Carbamazepine (brand name vs generic drugs), Lamotrigine (brand name vs generic drugs), levetiracetam (brand name vs generic drugs), Topiramate (brand name vs generic drugs), Zonisamide (brand name vs generic drugs), Phenytoin sodium (brand name vs generic drugs); Drug
Lead sponsor: Food and Drug Administration (FDA); Federal
Eligibility: 18 Years to 76 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Herpes Zoster
Interventions: Personalized letter, Flyer advertisement, Newspaper press release; Other
Lead sponsor: University of Tennessee; Other
Eligibility: 60 Years and older
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 3
States / cities: Johnson City, Tennessee • Manchester, Tennessee • Murfreesboro, Tennessee

Conditions: Heart Failure, Congestive
Interventions: Intervention; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 4
States / cities: Palo Alto, California • Denver, Colorado • Richmond, Virginia + 1 more

Conditions: Dementia
Interventions: PRIDE; Other
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Chicago, Illinois • Lake Forest, Illinois • Palos Heights, Illinois

Conditions: Acute Kidney Injury
Interventions: Acute Kidney Injury in Care Transitions (ACT), Usual Care; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 2,260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Mankato, Minnesota • Rochester, Minnesota • Eau Claire, Wisconsin

Search by objective public record fields.

Lupus Nephritis Care Pathway

Cardiovascular Intervention Improvement Telemedicine Study

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

COVID-19 Bivalent Booster Megastudy

Home-based Transitional Telecare for Older Veterans

Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

Enhancing a Sustainable Pharmacy-based Immunization Program in Two States

A Mobile Health and Wellness Coaching Intervention for Weight Loss

PRESSURE CHECK: Find Your Path to Better Health

Novel Combination Therapy for Osteoporosis in Men

A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly

Enoxaparin Metabolism in Reconstructive Surgery Patients

A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy

Trial of Low and High Intensity Strategies to Maintain BP Control

A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

Characterization of Epilepsy Patients BEEP 2b

The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

Patient-Centered Heart Failure Trial

Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia

Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial